Author

M Zhuo

Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

Observed institution: Merck & Co., Inc., Rahway, NJ, USA (United States)

OpenAlex ID: A5159700289

Efficacy of enlicitide across ESC cardiovascular risk categories in two CORALreef phase 3 trials

2026 · E S G Stroes, C M Ballantyne, et al. · European Heart Journal

Works count: 1

Citation count:

H-index:

I10-index: